Ferrous sulfate + Folic acid Medicinal Tablets 200MG + 0.25MG 10*10& acute;s / Box - AIA-1
Ferrous sulfate + Folic acid Medicinal Tablets 200MG + 0.25MG 10*10& acute;s / Box For Sale, Most Competitive Price, Fast Delivery, Custom Service, Wholesale Ferrous sulfate + Folic acid Medicinal Tablets 200MG + 0.25MG 10*10& acute;s / Box, Made in China, High Quality Products!, China cheap prodocuts, china suppliers Supplier, Manufacturer.
Ferrous sulfate+Folic acid Medicinal Tablets 200MG+0.25MG 10*10& acute;s / Box
?
FERROUS?SULFATE?+?FOLIC?ACID?TABLETS
?
COMPOSITION:
Each?tablet?contains?200mg?ferrous?sulfate?and?0.4mg?folic?acid.?
?
PHARMACOLOGICAL?ACTION:
Iron?is?an?essential?trace?element?that?is?required?for?the?formation?of?haemoglobin?and?myoglobin?important?
components?of?the?blood.?Ferrous?sulfate?+?Folic?acid?tablets?also?contain?a?sufficient?amount?of?folic?acid?to
?prevent?the?development?of?folate?deficiency?during?pregnancy.
?
INDICATIONS:
Ferrous?sulfate?+?Folic?acid?is?indicated?in?pregnancy?for?the?prevention?and?treatment?of?iron?deficiency
?anaemia?and?to?supply?a?maintenance?dosage?of?folic?acid.?It?is?also?indicated?for?the?general?treatment?of?
iron?deficiency?of?concomitant?folic?acid?deficiency?in?non-pregnant?patients.
?
CONTRA-INDICATIONS:
Ferrous?sulfate?+?Folic?acid?is?contra-indicated?in?patients?with?pernicious?anaemia.
The?use?of?Ferrous?sulfate?+?Folic?acid?is?contraindicated?in?the?presence?of?intestinal?diverticula?or?any?
intestinal?obstruction.
Iron?preparations?are?contraindicated?in?patients?with?hemochromatosis?and?hemosiderosis.
Iron?is?contraindicated?in?patients?receiving?repeated?blood?transfusions.
Oral?iron?preparations?are?contraindicated?when?used?concomitantly?with?parenteral?iron?therapy.
DOSAGE?AND?DIRECTIONS?FOR?USE:
The?usual?recommended?dose?for?non-pregnant?and?pregnant?adults?is?one?tablet?once?a?day,?or?as?prescribed?by?the?physician.
?
SIDE?EFFECTS?AND?SPECIAL?PRECAUTIONS:
Therapeutic?doses?of?iron?may?cause?gastro-intestinal?discomfort,?diarrhoea,?and?vomiting.?These?side-effects?have?been?reported?to?occur?in?up?to?20%?or?more?of?patients?treated?and?are?related?to?the?amount?
of ?elemental?iron.?Although?iron?is?better?absorbed?between?meals,?side?effects?can?be?reduced?by?taking?it?with,?or?immediately?after,?food.?Continued?administration?may?sometimes?cause?constipation.
Large?doses?of?ferrous?sulphate?may?have?irritant?and?corrosive?effects?on?the?gastro-intestinal?mucosa?and?necrosis?and?perforation?may?occur:?stricture?formation?may?subsequently?follow.?
Symptoms,?which?may?not?appear?for?several?hours,?include?epigastric?pain,?diarrhoea,?vomiting?and
?haematemesis.?Circulatory?failure?may?follow?if?the?diarrhoea?and?haemorrhage?are?severe.?Hours?or?days
?later,?after?apparent?recovery,?metabolic?acidosis,?convulsions,?and?coma?may?occur.?If?the?patient?survives,?
symptoms?of?acute?liver?necrosis?may?develop?and?may?lead?to?death?due?to?hepatic?coma.
?
STORAGE?INSTRUCTIONS:
Store?below?30°C?in?well?closed?container.?
Keep?out?of?reach?of?children.
?
ZHEJIANG MEDICINES&HEALTH PRODUCTS I/E CO.,LTD
Address: 101-2, N. Zhongshan Road, Hangzhou, Zhejiang, China (Mainland), Hangzhou, Zhejiang, China, 310000
Tel: 86-571-28935880
Zhejiang Medicines and Health Products Import &Export Co., Ltd (ZMC) is a subsidiary of Zhejiang International Business Group Co., Ltd. ZMC has evolved from a former state-owned enterprise in 1999 into a shareholding company with modern corporate governance structure and has been listed ever since 1990 among the top 500 exporters of China for 16 consecutive years.
Through incessant efforts over the years on the exploitation for new and high quality products that help better meet our customers鈥?needs and strengthen the competitiveness, our export revenue in 2014 hit a record high of USD 589 millions,and listed among the top 5 export of pharmacetical formulations in China,2013 and 2014.
We have established extensive and pleasant working ties with numerous manufacturers within China on a long-term basis and enjoyed a reliable marketing network in over 100 countries and regions in Asia, Europe, America, Africa and Oceania.
In recent years, according to the needs of our business development, extension of supply chain and strategic objectives, ZMC has invested in over 10 related manufactures in the form of share holding or share purchasing, thus boosting the marketing abroad for the related export products
